M6P Therapeutics

M6P Therapeutics

Biotechnology Research St. Louis, Missouri, United States 20 employees
Employees
20
Contacts
4
Emails
4
Phones
3

M6P Therapeutics Overview

Headquarters
St. Louis, Missouri, United States
Industry
Biotechnology Research
Employees
20
Founded
2017
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About M6P Therapeutics

M6P Therapeutics is developing the next-generation enzyme replacement and gene therapies for lysosomal storage disorders. We have discovered a novel method for significantly increasing mannose-6-phosphate phosphorylation of various lysosomal enzymes. This allows for markedly improved enzyme delivery to target tissues and promises improved clinical outcomes.

M6P Therapeutics Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
3
75.0% coverage

M6P Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Gavin Maitland Owner at Fleming CFO
Email Phone
Russell Gotschall Vice President, R&D at M6p Therapeutics
Email Phone
Catherine Foulon President and Lead Reg-cmc Consultant
Email Phone
Steve Walker Laboratory Manager at M6p Therapeutics
Email

Employees by Management Level

Executive 4 profiles
Individual contributor 4 profiles
Associate / junior 2 profiles
Manager 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 2 2 1
Executive 1 1 0

M6P Therapeutics Tech Stack

Data / AI 3 profiles

Compare Similar Companies to M6P Therapeutics